Entries by CURC

“Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer” appeared in NEJM • Neal Shore, MD among the contributing authors

The publication titled “Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer” appeared in The New England Journal of Medicine online yesterday and will appear in the June 28 print edition. Click here to read full article Two associated articles, an Editorial titled “Progress in Nonmetastatic Prostate Cancer” click here to read and a Perspective titled […]

Optimizing the treatment of metastatic castration‑resistant prostate cancer: a Latin America perspective

Dr. Shore, co -author Prostate cancer is a significant burden and cause of mortality in Latin America. This article reviews the treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) and provides consensus recommendations to assist Latin American prostate cancer specialists with clinical decision making. click here to read more

A Revolutionizing Time in Immuno-Oncology for Bladder Cancer – Neal Shore

There has been a limited number of new therapeutics, particularly in the area of patients who would benefit from advanced systemic bladder cancer treatments. Dr. Neal Shore reviews some pioneering work from the past such as MVAC and gemcitabine platinum based combinations but he notes those treatments are where things were left for many many […]